Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07686224Not ApplicableNot Yet Recruiting

Evaluation of the Nutritional Value of a New Hydrolysed Rice Protein-based Formula

Role: collaborator

NCT07603193Enrolling By Invitation

Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream

Role: collaborator

NCT06185829Not ApplicableRecruiting

Evaluating the Benefit of Hypnoanalgesia Versus Neuroleptanalgesia During Hand Surgery

Role: collaborator

NCT06228365Not ApplicableRecruiting

Minimally Invasive Superficial Venous Insufficiency Surgery and Digital Sedation

Role: collaborator

NCT06185803Active Not Recruiting

Predictors of Anterior Patellofemoral Pain After Anterior Cruciate Ligament Reconstruction

Role: collaborator

NCT06479772Completed

Evaluation of the Potential Impact of an Artificial Intelligence Solution in Second Reading of Organized Screening.

Role: collaborator

All 6 trials loaded